Indomethacin → HCID 67427091, compound
Reaction equation
[NH2:1][CH2:2][CH2:3][O:4][CH2:5][CH2:6][NH:7][C:8](=[O:14])[O:9][C:10]([CH3:13])([CH3:12])[CH3:11].[CH3:15][C:16]1[N:24]([C:25]([C:27]2[CH:28]=[CH:29][C:30]([Cl:33])=[CH:31][CH:32]=2)=[O:26])[C:23]2[CH:22]=[CH:21][C:20]([O:34][CH3:35])=[CH:19][C:18]=2[C:17]=1[CH2:36][C:37](O)=[O:38].CCN=C=NCCCN(C)C>CC#N.CCOC(C)=O>[Cl:33][C:30]1[CH:29]=[CH:28][C:27]([C:25]([N:24]2[C:23]3[C:18](=[CH:19][C:20]([O:34][CH3:35])=[CH:21][CH:22]=3)[C:17]([CH2:36][C:37]([NH:1][CH2:2][CH2:3][O:4][CH2:5][CH2:6][NH:7][C:8](=[O:14])[O:9][C:10]([CH3:11])([CH3:13])[CH3:12])=[O:38])=[C:16]2[CH3:15])=[O:26])=[CH:32][CH:31]=1Participants
6
Procedure
tert-Butyl 2-(2-aminoethoxy)ethylcarbamate (150 mg, 0.735 mmol) was then taken up in CH3CN (10 mL) along with indomethacin (263 mg, 0.735 mmol) and EDCI (155 mg, 0.81 mmol). The resulting reaction mixture was stirred at room temperature for 18 h. It was then diluted with EtOAc (20 mL), washed with saturated aqueous NaHCO3, brine, dried over Na2SO4, filtered and concentrated under reduced pressure. The resulting residue was purified by silica gel chromatography (9:1 CH2Cl2/MeOH) to afford 310 mg of tert-butyl 2-(2-(2-(1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)acetamido)ethoxy)ethylcarbamate (78%).
Workup
- customThe resulting reaction mixture
- washwashed with saturated aqueous NaHCO3, brine
- dry with materialdried over Na2SO4
- filtrationfiltered
- concentrationconcentrated under reduced pressure
- customThe resulting residue was purified by silica gel chromatography (9:1 CH2Cl2/MeOH)
Sources & evidence
- ORD record
- ord-e3a01a9193fe4e6ba5c9ca4521cffef2
- Source dataset
- uspto-grants-2015_12
- Patent number
- US09216224B2
Reaction notes
Loading…